- US-listed companies
- IMMUCELL CORP
IMMUCELL CORPICCC
Market cap
$28.14M
P/E ratio
Dec 31, 2013 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | |
Product sales | - | 14 | 15 | 19 | 19 |
Costs of goods sold | - | 7 | 8 | 11 | 11 |
Gross margin | 3 | 7 | 7 | 9 | 8 |
Product development expenses | 1 | 4 | 4 | 4 | 4 |
Sales and marketing expenses | 986,766 | 2 | 2 | 3 | 3 |
Administrative expenses | 939,192 | 2 | 2 | 2 | 2 |
Operating expenses | 3 | 8 | 8 | 8 | 10 |
NET OPERATING (LOSS) INCOME | -19,552 | -953,908 | -1,380,353 | 257,385 | -2,298,943 |
Other expenses, net | - | - | 348,100 | -326,512 | -187,190 |
LOSS BEFORE INCOME TAXES | 205,260 | -1,267,413 | -1,032,253 | -69,127 | -2,486,133 |
Income tax expense | 87,865 | 28,174 | -10,136 | 9,165 | 7,672 |
NET LOSS | 117,395 | -1,295,587 | -1,022,117 | -78,292 | -2,493,805 |
Basic net loss per share (in Dollars per share) | 0.04 | -0.19 | -0.14 | -0.01 | -0.32 |
Diluted net loss per share (in Dollars per share) | 0.04 | -0.19 | -0.14 | -0.01 | -0.32 |